| A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer (NCT00399789) | AEterna Zentaris | 2004-09-01 |
| Phase II Study of DMXAA (ASA404) in Combination With Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer (NCT00832494) | Antisoma Research | 2004-09-01 |
| Phase II Iressa + Irradiation Followed by Chemo in NSCLC (NCT00333294) | AstraZeneca | 2004-09-01 |
| Adjuvant Cisplatin and Docetaxel in Non Small Cell Lung Cancer (NCT00582634) | University of Wisconsin, Madison | 2004-09-01 |
| Multicenter Phase 2 Trial Evaluating Cisplatin-Gemcitabine With Concomitant Thoracic Radiotherapy for Treatment of Inoperable Stage III Non Small Cell Lung Cancer (NCT00192036) | Eli Lilly and Company | 2004-08-01 |
| Iressa in the Treatment of Brain Metastases From Non Small Cell Lung Cancer (NCT00234442) | AstraZeneca | 2004-07-01 |
| Study Of SU011248 In Combination With Docetaxel In Patients With Advanced Cancer (NCT00712504) | Pfizer | 2004-07-01 |
| Docetaxel and Carboplatin Versus Docetaxel as Second Line Treatment in Patients With Non-Small-Cell Lung Carcinoma (NSCLC) (NCT00430651) | Hellenic Oncology Research Group | 2004-07-01 |
| Study of Oxaliplatin and Gemcitabine With or Without Bevacizumab to Treat Advanced Non-Small Cell Lung Cancer (NCT00217282) | Mt. Sinai Medical Center, Miami | 2004-06-01 |
| Phase II Trial to Correlate Radiographic Response Induced By Gefitinib With Mutations in the Protein-Tyrosine Kinase Domain of the EGF Receptor Gene (NCT00588445) | Memorial Sloan Kettering Cancer Center | 2004-06-01 |
| Alternating Cycles of Carboplatin/Gemcitabine and Carboplatin/Taxol for Advanced Stage NSCLC (NCT00259675) | University of Saskatchewan | 2004-05-01 |
| A Phase I Study of ZD1839 and Palliative Thoracic Radiotherapy in Patients With Non-small-cell Lung Cancer (NCT00255489) | AstraZeneca | 2004-05-01 |
| Phase II Study of Therapy With PS 341 in Patients With Advanced Stage Non Small Cell Lung Cancer (NCT00200382) | Rasim Gucalp | 2004-05-01 |
| Iscar for Second Line Treatment of Advanced Non-Small Cell Lung Cancer (NCT00283478) | Kentuckiana Cancer Institute | 2004-05-01 |
| A Study of Tarceva (Erlotinib) Monotherapy in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) (NCT01996332) | Hoffmann-La Roche | 2004-04-01 |
| Randomized Trial With Vinorelbine and Gemcitabine Versus Docetaxel and Gemcitabine in Patients With Non-Small Cell Lung Cancer (NCT00441740) | Hellenic Oncology Research Group | 2004-04-01 |
| Study for Patients Who Have Benefited and Tolerated Prior Panitumumab Treatment (NCT00425204) | Amgen | 2004-03-01 |
| A Trial of Carboplatin and Gemcitabine Versus Gemcitabine Alone in Patients With Non-Small-Cell Lung Cancer (NCT00190710) | Eli Lilly and Company | 2004-03-01 |
| Adjuvant Celecoxib in Completely Resected pN1-2 NSCLC Patients (NCT00211952) | Medical University of Gdansk | 2004-03-01 |
| Erlotinib vs. Standard Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) and Eastern Cooperative Oncology Group (ECOG)Performance Status (PS) 2 (NCT00085839) | OSI Pharmaceuticals | 2004-02-01 |
| TLK286 (Telcyta) in Combination With Cisplatin for Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) (NCT00077883) | Telik | 2004-02-01 |
| NM404 as an Imaging Agent in Patients With NSCLC (NCT00582283) | University of Wisconsin, Madison | 2004-01-14 |
| A Comparison of Two Doses of Pemetrexed in Patients Who Have Lung Cancer (NCT00078260) | Eli Lilly and Company | 2003-12-01 |
| Ispinesib In Patients With Advanced Or Metastatic Non-Small Cell Lung Cancer (NCT00085813) | GlaxoSmithKline | 2003-12-01 |
| Trial of ABI-007 Administered Weekly in Chemotherapy Naive Patients With Advanced Non-Small Cell Lung Cancer (NCT00073723) | Celgene Corporation | 2003-12-01 |
| Induction Chemotherapy Using Paclitaxel, Carboplatin, CPT-11 With Pegfilgrastim (NCT00280787) | UNC Lineberger Comprehensive Cancer Center | 2003-11-01 |
| Iressa Case Control Study in Japan (NCT00252759) | AstraZeneca | 2003-11-01 |
| CT Perfusion Scans for Assessment of Lung Cancer Before and After Chemo +/- Radiotherapy (NCT00188214) | University Health Network, Toronto | 2003-10-01 |
| Harvesting Cells for Experimental Cancer Treatments (NCT00068003) | National Cancer Institute (NCI) | 2003-09-08 |
| Trial of Perioperative Chemotherapy (Gemcitabine and Cisplatin) and Adjuvant Chemoradiotherapy (With Weekly Low Dose Gemcitabine) in Patients With Lung Cancer With Positive Nodes (NCT00490659) | Eli Lilly and Company | 2003-09-01 |
| A Study of ABT-751 in Patients With Non-Small Cell Lung Cancer (NCT00073151) | Abbott | 2003-09-01 |
| Iressa 2nd Line Phase III Study in Japan (NCT00252707) | AstraZeneca | 2003-09-01 |
| Comparison of IV Topotecan/Docetaxel to Docetaxel Alone in Second-Line Stage IIIB/IV Non-Small Cell Lung Cancer (NCT00065182) | GlaxoSmithKline | 2003-08-14 |
| OSI-774 (Erlotinib, Tarceva) in Elderly Patients (NCT00200395) | Montefiore Medical Center | 2003-07-02 |
| Pegfilgrastim Given Same Day As or Day After Carboplatin and Docetaxel in Advanced Metastatic Non-Small Cell Lung Cancer (NSCLC) (NCT00094822) | Amgen | 2003-07-01 |
| Trial of Pemetrexed or Pemetrexed With Gemcitabine for Patients With Advanced Lung Cancer Who Are Not Eligible for Platinum-Based Chemotherapy and Have Not Previously Been Treated With Chemotherapy (NCT00489983) | Eli Lilly and Company | 2003-07-01 |
| Safety and Effect of Pertuzumab in Patients With Advanced Non-Small Cell Lung Cancer, Which Has Progressed After Prior Chemotherapy (NCT00063154) | Genentech, Inc. | 2003-07-01 |
| Phase II Study of Docetaxel + ZD1839 in Elderly Patients With Non-Small Cell Lung Cancer (NCT00231465) | H. Lee Moffitt Cancer Center and Research Institute | 2003-07-01 |
| Docetaxel Plus Cisplatin Followed by Gemcitabine Versus Gemcitabine Plus Cisplatin Followed by Docetaxel for Non-Small Cell Lung Cancer (NSCLC) (NCT00173888) | National Taiwan University Hospital | 2003-07-01 |
| Efficacy Study of GEMOX Combination and Vinorelbine in NSCL Patients (NCT00271271) | Sanofi | 2003-06-01 |
| ABX-EGF as Second Line Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC) (NCT00101920) | Amgen | 2003-06-01 |
| Docetaxel, Irinotecan, and Carboplatin in Extensive Stage Non-Small Cell Lung Cancer (NCT00264134) | Kentuckiana Cancer Institute | 2003-06-01 |
| Safety and Immunogenicity of Recombinant DNA and Adenovirus Expressing L523S Protein in Early Stage Non-Small Cell Lung Cancer (NCT00062907) | Corixa Corporation | 2003-05-01 |
| Phase II Study in Patients With Recurrent Non-Small-Cell Lung Cancer (NCT00063388) | Eli Lilly and Company | 2003-05-01 |
| Prospective Study of Quality of Life in Non-small Cell Lung Cancer (NSCLC) Patients Treated With/Without Postoperative Radiotherapy (NCT01112631) | Maria Sklodowska-Curie National Research Institute of Oncology | 2003-04-01 |
| Elderly NSCLC/D vs DP (JCOG0207) (NCT00190476) | Japan Clinical Oncology Group | 2003-04-01 |
| Gemcitabine or Gemcitabine Plus Docetaxel After Cisplatin, Etoposide and Radiation in Non Small Cell Lung Cancer (NSCLC) (NCT00191139) | Eli Lilly and Company | 2003-03-01 |
| Study of S-3304 in Patients With Locally Advanced Non-Small Cell Lung Cancer (NCT00078390) | Shionogi | 2003-02-01 |
| Evaluation of Carboplatin Plus Gemcitabine Followed by Concomitant Chemoradiation for Non-resectable Stage III NSCLC (NCT00463515) | University Hospital, Antwerp | 2003-01-01 |
| Investigation of Safety and Efficacy of SB Injection in Patients With Advanced and Metastatic Non-small Cell Lung Cancer (NCT01305967) | SBPharmaceutical IND, Co., LTD | 2003-01-01 |
| Trial of Docetaxel Versus Vinorelbine as 1st Line Treatment in Elderly Patients With Non-Small-Cell Lung Cancer (NSCLC) (NCT00441922) | Hellenic Oncology Research Group | 2003-01-01 |
| Trial Comparing 3 and 4 Week Regimen of Gemcitabine and Cisplatin in Patients With Lung Cancer (NCT00489996) | Eli Lilly and Company | 2003-01-01 |
| Three Modalities of Treatment in Operable and Resectable Stage IIIA (T1-3, N2) Non-Small Cell Lung Cancer (NSCLC) (NCT00198367) | Hospices Civils de Lyon | 2003-01-01 |
| Phase II Study of Weekly Paclitaxel (BMS-181339) in Patient With Non-Small Cell Lung Cancer (NSCLC) (NCT01024062) | Bristol-Myers Squibb | 2002-12-01 |
| Phase 2 Study of VELCADE Alone or VELCADE® Plus Docetaxel in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer (NCT00051974) | Millennium Pharmaceuticals, Inc. | 2002-12-01 |
| Treatment for Patients With Non-Small Cell Lung Cancer Who Developed Anemia Due to Chemotherapy (NCT00120679) | Amgen | 2002-10-01 |
| Prevention of Tumor Spread Due to Lung Cancer Surgery (NCT00341380) | National Institute of Environmental Health Sciences (NIEHS) | 2002-09-24 |
| A FRENCH SURVEY OF THE DIAGNOSTIC AND THERAPEUTIC MANAGEMENT OF ELDERLY PEOPLE WITH HISTOLOGICALLY/CYTOLOGICALLY CONFIRMED LUNG CANCER. (NCT00198406) | Intergroupe Francophone de Cancerologie Thoracique | 2002-09-01 |
| Iressa/Docetaxel in Non-Small-Cell Lung Cancer (NCT00048087) | M.D. Anderson Cancer Center | 2002-08-01 |
| Hyperthermia/Thermal Therapy With Chemotherapy to Treat Inoperable or Metastatic Tumors (NCT00178698) | The University of Texas Health Science Center, Houston | 2002-07-01 |
| Neulasta® in Subjects With Advanced Non-Small-Cell Lung Cancer (NSCLC) During Chemotherapy (NCT00115206) | Amgen | 2002-07-01 |
| Taxotere Combinations as First Line Therapy for Locally Advanced Unresectable or Metastatic Non-small Cell Lung Cancer. (NCT00425191) | Sanofi | 2002-07-01 |
| MILES-02: Study of Chemotherapy Treatment and Toxicity in Elderly Patients With Advanced Non Small Cell Lung Cancer (NCT00401492) | National Cancer Institute, Naples | 2002-06-01 |
| Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer (NCT00050960) | Eisai Inc. | 2002-05-01 |
| Functional Imaging of Treatment Effects: A Companion Protocol to a Study of Extracranial Stereotactic Radioablation in Early Stage Non-Small Cell Lung Cancer (NCT00246116) | Indiana University | 2002-02-01 |
| Cisplatin/Etoposide/Radiotherapy +/- Consolidation Docetaxel in Advanced Stage III Non-Small Cell Lung Cancer (NCT00216125) | Nasser Hanna, M.D. | 2002-02-01 |
| ABX-EGF in Combination With Paclitaxel and Carboplatin for the Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC) (NCT00034346) | Amgen | 2002-01-01 |
| Randomized Study of Positron Emission Tomography - Computed Tomography (PET/CT) in Pre-Operative Staging of Lung Cancer (NCT00867412) | Rigshospitalet, Denmark | 2002-01-01 |
| An Open, Randomized, Multicentre, Phase II Pilot Study (NCT00293085) | Central European Cooperative Oncology Group | 2001-12-01 |
| Docetaxel and Gemcitabine With Filgrastim-SD/01 Support in Patients With Advanced Non-Small Cell Lung Carcinoma (NCT00050674) | Schwartzberg, Lee, M.D. | 2001-11-01 |
| Chemotherapy/Radiotherapy Versus Concomitant Chemotherapy Followed by Radiotherapy in Stage IIIB Non-small Cell Lung Cancer (NCT01652820) | Spanish Lung Cancer Group | 2001-10-01 |
| Oral Topotecan Versus Intravenous Docetaxel In Pretreated, Advanced Non-Small Cell Lung Cancer (NCT00049998) | GlaxoSmithKline | 2001-10-01 |
| A Study of CBT-1 and Paclitaxel With Carboplatin in Patients With Advanced Inoperable Non-small Cell Lung Cancer (NCT00437749) | CBA Research | 2001-08-01 |
| Radiofrequency Ablation of Pulmonary Tumors Response Evaluation (NCT00690703) | Angiodynamics, Inc. | 2001-07-01 |
| Follow-up of Patients With Curative-intent Surgical Resection for NSCLC (NCT00199615) | University Hospital, Limoges | 2001-04-01 |
| A Phase III Study of the Efficacy of Taxotere/Aptosyn Versus Taxotere/Placebo in Non-Small Cell Lung Cancer Patients (NCT00085826) | Astellas Pharma Inc | 2001-04-01 |
| Randomized Phase III Trial of Surgery Alone or Surgery Plus Preoperative Gemcitabine-Cisplatin in Early Stages NSCLC (NCT00191126) | Eli Lilly and Company | 2000-09-01 |
| Phase I/II Trial of Infusional Gemcitabine in Combination With Carboplatin in Chemonaive Non-small Cell Carcinoma (NCT00212043) | National University Hospital, Singapore | 2000-07-01 |
| K-RAS and EGFR in Lung Cancer (NCT03951233) | Hellenic Cooperative Oncology Group | 2000-03-01 |
| Phase I and II Study Of Stereotactic Body Radiotherapy in Medically Unresectable Patients With Stage 1 NSCLC (NCT00246181) | Jill Deluca | 1999-12-01 |
| Neoadjuvant or Adjuvant Chemotherapy in Patients With Operable Non-small-cell Lung Cancer (NCT00913705) | Spanish Lung Cancer Group | 1999-09-01 |
| Lung Tumour Volume Database (NCT00351598) | Trans Tasman Radiation Oncology Group | 1999-09-01 |
| Gemcitabine/Cisplatin Versus Gemcitabine/Epirubicin for Non-Small Cell Lung Cancer (NSCLC) (NCT00154739) | National Taiwan University Hospital | 1998-10-01 |
| Neoadjuvant Chemotherapy in Non Small Cell Lung Cancer (NSCLC) Stages IB, IIA, IIB, and IIIA/T3 (NCT00273507) | Rigshospitalet, Denmark | 1998-01-01 |
| Neoadjuvant Chemotherapy Plus/Minus Surgery in Non-Small-Cell Lung Cancer (NSCLC) Stage IIIA/N2 (NCT00273494) | Rigshospitalet, Denmark | 1998-01-01 |
| Assisted-VATS Sleeve Lobectomy for Non-small Cell Lung Cancer (NCT00997724) | The First Affiliated Hospital of Guangzhou Medical University | 1996-02-01 |
| Preoperative Twice Daily Chemoradiation in Addition to Chemotherapy Prior to Surgery in Stage III Non-Small Cell Lung Cancer (NSCLC) (NCT00176137) | Heidelberg University | 1995-10-01 |
| A Study Of Ranpirnase(Onconase®) To Pemetrexed Plus Carboplatin In Patients With Non-Squamous Non-Small Cell Lung Cancer (NCT01184287) | Tamir Biotechnology, Inc. | |
| Study of Alimta® (Pemetrexed) Plus VELCADE® (Bortezomib) or Alimta Alone or VELCADE Alone in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Prior Therapy (NCT00343720) | Millennium Pharmaceuticals, Inc. | |
| Evaluation of Thoracic Tumors With 18F-FMT and 18F-FDG PET-CT A Clinicopathological Study (NCT00698373) | Gunma University | |
| Expanded Access Multicenter Study of Lucanix® (Belagenpumatucel-L) (NCT01279798) | NovaRx Corporation | |
| Expanded Access Program of Neladalkib (NVL-655) for Patients With Advanced ALK+ NSCLC or Other ALK+ Solid Tumors (NCT06834074) | Nuvalent Inc. | |
| Expanded Access of Sotorasib (NCT04667234) | Amgen | |
| Managed Access Programs for INC280, Capmatinib (NCT04741789) | Novartis Pharmaceuticals | |
| Angiogenesis With Positron Emission Tomography (PET) Tracer Uptake (NCT00671242) | Gunma University | |
| Reducing Symptom Burden - Non Small Cell Lung Cancer (NSCLC) (NCT01048983) | M.D. Anderson Cancer Center | |
| Expanded Access Study of Alectinib for Participants With Anaplastic Lymphoma Kinase (ALK)-Rearranged Non-Small Cell Lung Cancer (NSCLC) After Disease Progression on or Intolerance to Prior ALK Tyrosine Kinase Inhibitor Therapy (NCT02271139) | Genentech, Inc. | |
| An Expanded Access Study of Brigatinib for Patients With ALK-positive Advanced Non-Small Cell Lung Cancer (NCT02784158) | Ariad Pharmaceuticals | |
| Expanded Access for the Treatment of Cancers With Rearranged During Transfection (RET) Activation (NCT03906331) | Eli Lilly and Company | |
| Gefitinib and Radiation Therapy in Treating Patients With Inoperable Stage I or Stage II Non-Small Cell Lung Cancer (NCT00268255) | Barbara Ann Karmanos Cancer Institute | |